Amgen Inc (NASDAQ:AMGN) on 12/07/2018 declared a dividend of $ 1.4500 per share payable on March 08, 2019 to shareholders of record as of February 15, 2019. Dividend amount recorded is an increase of $ 0.13 from last dividend Paid.

Amgen Inc (NASDAQ:AMGN) has paid dividends since 1997, has a current dividend yield of 2.9144265652% and has increased its dividends for 6 successive years.

Amgen Inc's market cap is $ 126,812,953,190 and has a PE ratio of 52.10. The stock price closed yesterday at $ 199.01 and has a 52 week low/high of $ 163.31 and $ 210.19.

Amgen is a global biotechnology company that discovers, develops, manufactures and delivers human therapeutics. Co. focuses its research and development on human therapeutics for the treatment of illness primarily in the areas of oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and neuroscience. Co.'s principal products include Enbrel®, Neulasta®, Aranesp®, Prolia®, Sensipar®/Mimpara®, XGEVA®, and EPOGEN®. In addition, Co. markets several other products, including KYPROLIS® (carfilzomib), Vectibix® (panitumumab), Nplate® (romiplostim), Repatha® (evolocumab), BLINCYTO® (blinatumomab), IMLYGIC® (talimogene laherparepvec) and Corlanor® (ivabradine).

For more information on Amgen Inc click here.